Association between sex steroid hormones and hematocrit in a nationally representative sample of men

Journal of Andrology

Volumn 33, Issue 6, 2012, Pages 1332-1341

  Paller, Channing J ^a   Shiels, Meredith S ^b   Rohrmann, Sabine ^c   Menke, Andy ^b   Rifai, Nader ^d   Nelson, William G ^a,e   Platz, Elizabeth A ^a,b,e   Dobs, Adrian S ^a,e,f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol; Nhanes iii; Sex hormone binding globulin; Testosterone

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; HEMATOCRIT; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANEMIA; CROSS-SECTIONAL STUDIES; ESTRADIOL; GONADAL STEROID HORMONES; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; SEX HORMONE-BINDING GLOBULIN; STROKE; TESTOSTERONE;

EID: 84874407727     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.111.015651     Document Type: Article

References (41)

1. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71-80.
2. Beers MR, Porter RS, Jones TV, Kaplan JL, Berkwits M. The Merk Manual of Diagnosis and Therapy. 18th ed. Whitehouse Station, NJ: Merk Research Laboratories; 2006.
3. Besa EC. Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions. Semin Hematol. 1994;31:134-145.
4. Bukowski C, Grigg MA, Longcope C. Sex hormone-binding globulin concentration: differences among commercially available methods. Clin Chem. 2000;46:1415-1416.
5. Carter C, McGee D, Reed D, Yano K, Stemmermann G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am Heart J. 1983;105:674-679.
6. Chumlea WC, Guo SS, Kuczmarski RJ, Flegal KM, Johnson CL, Heymsfield SB, Lukaski HC, Friedl K, Hubbard VS. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord. 2002;26:1596-1609.
7. Dobs AS, MeikleAW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab. 1999;84:3469-3478.
8. Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2005; 128:275-290.
9. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 17th ed. New York, NY: McGraw Hill Medical; 2008.
10. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589-598.
11. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM, Longo DL. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006;166:1380-1388.
12. Fonseca R, Rajkumar SV, White WL, Tefferi A, Hoagland HC. Anemia after orchiectomy. Am J Hematol. 1998;59:230-233.
13. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J. 1994;127:674-682.
14. Garn SM, Ryan AS, Abraham S, Owen G. Suggested sex and age appropriate values for "low"and "deficient"hemoglobin levels. Am J Clin Nutr. 1981;34:1648-1651.
15. Greenspan FBJ. Basic and Clinical Endocrinology. 4th ed. East Norwalk, CT: Appleton & Lange; 1994.
16. Gunter E, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III). 1988-1994. Hyattsville, MD: Centers for Disease Control and Prevention; 1996.
17. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104:2263-2268.
18. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731.
19. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714-1717.
20. Joosten E, Pelemans W, Hiele M, Noyen J, Verhaeghe R, Boogaerts MA. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology. 1992;38:111-117.
21. Kato I, Nomura A, Stemmermann GN, Chyou PH. Determinants of sex hormone levels in men as useful indices in hormone-related disorders. J Clin Epidemiol. 1992;45:1417-1421.
22. Leon-Velarde F, Gamboa A, Chuquiza JA, Esteba WA, Rivera-Chira M, Monge CC. Hematological parameters in high altitude residents living at 4,355, 4,660, and 5,500 meters above sea level. High Alt Med Biol. 2000;1:97-104.
23. Mukundan H, Resta TC, Kanagy NL. 17b-estradiol decreases hypoxic induction of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol. 2002;283:R496-R504.
24. Orwoll E, Lambert LC, Marshall LM, PhippsK, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings S. Testosterone and estradiol among older men. J Clin Endocrinol Metab. 2006;91:1336-1344.
25. Penninx BW. Anemia and Physical Health Decline in Old Age. Amsterdam, Netherlands: Springer; 2007.
26. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1. 1994;(32):1-407.
27. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Riboli E, Toniolo P, Kaaks R. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev. 2002;11:1065-1071.
28. Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health and Nutrition Examination Survey. BJU Int. 2005;96:77-82.
29. Saad F, Gooren L, Haider A, Yassin A. An exploratory study of the effects of 12month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome. Arch Androl. 2007;53:353-357.
30. Sih R, Morley JE, Kaiser FE, Perry HM3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82:1661-1667.
31. Smieja MJ, Cook DJ, Hunt DL, Ali MA, Guyatt GH. Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. CMAJ. 1996;155:691-696.
32. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000;85:2670-2677.
33. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-1098.
34. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
35. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105:1785-1790.
36. Wannmethee SG, Shaper AG, Whincup PH. Ischaemic heart disease: association with haematocrit in British Regional Heart Study. J Epidemiol Community Health. 1994;48:112-118.
37. Weber JP, Walsh PC, Peters CA, Spivak JL. Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men. Am J Hematol. 1991;36:190-194.
38. Whitehead TP, Robinson D, Allaway SL, Hale AC. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clin Lab Haematol. 1995;17:131-138.
39. Winters SJ, Wang C; Fortigel Study Group. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older. J Androl. 2009;31:281-287.
40. Yeap BB, Beilin J, Shi Z, Knuiman MW, Olynyk JK, Bruce DG, Milward EA. Serum testosterone levels correlate with haemoglobin in middle-aged and older men. Intern Med J. 2009;39:532-538.
41. Yi S, Selvin E, Rohrmann S, Basaria S, Menke A, Rifai N, Guallar E, Platz EA, Astor B. Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf). 2009;71:246-252.